Preoperative and pathological staging of NSCLC: Retrospective analysis of 291 cases;Estadiamentos pré-operatório e patológico do CPNPC: Análise retrospectiva de 291 casos

Revista da Associacao Medica Brasileira

Volumn 56, Issue 2, 2010, Pages 237-241

  Younes, Riad Naim ^a   Schutz, Fabio Augusto Barros ^a   Gross, Jefferson Luiz ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Lung neoplasms; Neoplasm staging; Spiral computed; Tomography

Indexed keywords

EID: 77953667057     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0104-42302010000200026     Document Type: Review

References (25)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71-96.
3. Ministério da Saúde. Secretaria de Atenção à Saúde. Instituto Nacional de Câncer. Coordenação de Prevenção e Vigilância de Câncer. Estimativas 2008: Incidência de câncer no Brasil. Rio de Janeiro: INCA; 2007.
4. Naruke T, Tsuchiya R, Kondo H, Asamura H. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. Ann Thorac Surg. 2001;71(6):1759-64.
5. Younes RN, Deutsch F, Badra C, Gross J, Haddad F, Deheinzelin D. Nonsmall cell lung cancer: evaluation of 737 consecutive patients in a single institution. Rev Hosp Clin Fac Med São Paulo. 2004;59(3):119-27.
6. Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med. 2004;350(4):379-92.
7. Naime FF, Younes RN, Kersten BG, Anelli A, Beato CA, Andrade RM, et al. Metastatic non-small cell lung cancer in Brazil: treatment heterogeneity in routine clinical practice. Clinics. 2007;62(4):397-404.
8. Santos PA, Rocha RS, Pipkin M, Silveira ML, Cypel M, Rios JO, et al. Concordance between clinical and pathological staging in patients with stages I or II non-small cell lung cancer subjected to surgical treatment. J Bras Pneumol. 2007;33(6):647-54.
9. th ed. New York (NY): Springer-Verlag; 2002.
10. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-74.
11. Sioris T, Jarvenpaa R, Kuukasjarvi P, Helin H, Saarelainen S, Tarkka M. Comparison of computed tomography and systematic lymph node dissection in determining TNM and stage in non-small cell lung cancer. Eur J Cardiothorac Surg. 2003;23(3):403-8.
12. Fernando HC, Goldstraw P. The accuracy of clinical evaluative intrathoracic staging in lung cancer as assessed by postsurgical pathologic staging. Cancer. 1990;65(11):2503-6.
13. Graham AN, Chan KJ, Pastorino U, Goldstraw P. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer. J Thorac Cardiovasc Surg. 1999;117(2):246-51.
14. Chong CF, Khoo KL, Lim TK, Chang AY, Lim HL, Lee CN, et al. Comparison of clinical with pathological nodal staging from systematic mediastinal lymph node dissection in early resectable non-small cell lung cancer. Singapore Med J. 2007;48(7):620-4.
15. Lopez-Encuentra A, Garcia-Lujan R, Rivas JJ, Rodriguez-Rodriguez J, Torres-Lanza J, Varela-Simo G. Comparison between clinical and pathologic staging in 2,994 cases of lung cancer. Ann Thorac Surg. 2005;79(3):974-9; discussion 9.
16. Cetinkaya E, Turna A, Yildiz P, Dodurgali R, Bedirhan MA, Gurses A, et al. Comparison of clinical and surgical-pathologic staging of the patients with non-small cell lung carcinoma. Eur J Cardiothorac Surg. 2002;22(6):1000-5.
17. Dales RE, Stark RM, Raman S. Computed tomography to stage lung cancer. Approaching a controversy using meta-analysis. Am Rev Respir Dis. 1990;141(5 Pt 1):1096-101.
18. Gdeedo A, Van Schil P, Corthouts B, Van Mieghem F, Van Meerbeeck J, Van Marck E. Prospective evaluation of computed tomography and mediastinoscopy in mediastinal lymph node staging. Eur Respir J. 1997;10(7):1547-51.
19. McLoud TC, Bourgouin PM, Greenberg RW, Kosiuk JP, Templeton PA, Shepard JA, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology. 1992;182(2):319-23.
20. Robinson LA, Wagner H, Jr., Ruckdeschel JC. Treatment of stage IIIA non-small cell lung cancer. Chest. 2003;123(1 Suppl):202S-20S.
21. Webb WR, Gatsonis C, Zerhouni EA, Heelan RT, Glazer GM, Francis IR, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology. 1991;178(3):705-13.
22. Roberts JR, Blum MG, Arildsen R, Drinkwater DC Jr., Christian KR, Powers TA, et al. Prospective comparison of radiologic, thoracoscopic, and pathologic staging in patients with early non-small cell lung cancer. Ann Thorac Surg. 1999;68(4):1154-8.
23. Pirronti T, Macis G, Sallustio G, Minordi LM, Granone P, Vecchio FM, et al. Evaluation of the "N" factor in nonsmall cell lung cancer. Correlation between computerized tomography and pathologic anatomy. Radiol Med. 2000;99(5):340-6.
24. Rodriguez Fernandez A, Gomez Rio M, Llamas Elvira JM, Sanchez-Palencia Ramos A, Bellon Guardia M, Ramos Font C, et al. Diagnosis efficacy of structural (CT) and functional (FDG-PET) imaging methods in the thoracic and extrathoracic staging of non-small cell lung cancer. Clin Transl Oncol. 2007;9(1):32-9.
25. Turkmen C, Sonmezoglu K, Toker A, Yilmazbayhan D, Dilege S, Halac M, et al. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high. Clin Nucl Med. 2007;32(8):607-12.